EBV LMP2A anticorps
EBV LMP2A
Reactivité: Epstein-Barr Virus (EBV)
IHC (p), WB
Hôte: Rat
unconjugated
-
- Antigène Tous les produits EBV LMP2A
- EBV LMP2A (Epstein-Barr Virus Latent Membrane Protein 2A (EBV LMP2A))
- Reactivité
- Epstein-Barr Virus (EBV)
-
Hôte
- Rat
-
Conjugué
- Cet anticorp EBV LMP2A est non-conjugé
-
Application
- Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
- Specificité
- DS-MB-03627 recognizes latent membrane protein 2A (LMP2A) of Epstein-Barr virus (EBV). EBV is a human herpes virus, which is associated with conditions such as Hodgkin's disease and Burkitt's Lymphoma and is the causative agent in mononucleosis in adolescents. EBV latently infects B lymphocytes. Infected B cells express EBV nuclear antigens and latent proteins LMP1, LMP2A and LMP2B. LMP2A forms aggregates in the plasma membranes of B lymphocytes, where it functions as a negative regulator of the Src and Syk protein tyrosine kinases. Studies show that LMP2A blocks B-cell receptor (BCR) signal transduction in EBV immortalized B cells in vitro and may play an important role in maintaining a latent EBV infection within the peripheral blood B cells of infected individuals. DS-MB-03627 specifically recognizes LMP2A and does not cross react with LMP2B.
- Attributs du produit
- Rat Anti-Epstein-Barr Virus LMP2A
- Purification
- Purified
- Immunogène
- Bacterial TrpE-LMP2A fusion protein
- Isotype
- IgG2a
-
-
- Restrictions
- For Research Use only
-
- Concentration
- IgG concentration 1.0 mg/ml
- Buffer
- Phosphate buffered saline
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C
-
- Antigène
- EBV LMP2A (Epstein-Barr Virus Latent Membrane Protein 2A (EBV LMP2A))
- Autre désignation
- Epstein-Barr Virus LMP2A (EBV LMP2A Produits)
- Synonymes
- anticorps -, anticorps LMP2A
- Classe de substances
- Viral Protein
-
Vous êtes ici:
